Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas
- DOI
- 10.3390/cancers12082307
- Published
- 2020-08-16
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers12082307,
title = {Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas},
author = {Camilo Jimenez and Vivek Subbiah and Bettzy Stephen and Junsheng Ma and Denai Milton and Mingxuan Xu and Abdualrazzak Zarifa and Fechukwu Omolara Akhmedzhanov and Apostolia Tsimberidou and Mouhammed Amir Habra and Jordi Rodon Anhert and Siqing Fu and Aung Naing},
year = {2020},
journal = {Cancers},
doi = {10.3390/cancers12082307},
url = {https://doi.org/10.3390/cancers12082307}
}RIS
TY - JOUR TI - Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas AU - Camilo Jimenez AU - Vivek Subbiah AU - Bettzy Stephen AU - Junsheng Ma AU - Denai Milton AU - Mingxuan Xu AU - Abdualrazzak Zarifa AU - Fechukwu Omolara Akhmedzhanov AU - Apostolia Tsimberidou AU - Mouhammed Amir Habra AU - Jordi Rodon Anhert AU - Siqing Fu AU - Aung Naing PY - 2020 JO - Cancers DO - 10.3390/cancers12082307 UR - https://doi.org/10.3390/cancers12082307 ER -
APA
Jimenez, C., Subbiah, V., Stephen, B., Ma, J., Milton, D., Xu, M., Zarifa, A., Akhmedzhanov, F. O., Tsimberidou, A., Habra, M. A., Anhert, J. R., Fu, S., & Naing, A. (2020). Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. Cancers. https://doi.org/10.3390/cancers12082307
Source records
- crossref · retrieved 2026-09-26T15:39:48.847Z